Journal of Central Nervous System Disease

Journal of Central Nervous System Disease is an open access journal from SAGE Publishing that covers clinical practice and research on disorders of the human brain and central nervous system. Its predecessor, Journal of Brain Disease, appeared in 2009, and the present title began with the 2010 volume. Its 2025 impact factor is 2.4.《中枢神经系统疾病杂志》是 SAGE 出版的一份开放获取期刊，关注人类大脑与中枢神经系统疾病的临床实践和研究。其前身《脑疾病杂志》于 2009 年面世，现名自 2010 年卷开始使用。该刊 2025 年影响因子为 2.4。

Scope

• The journal describes itself as an international, peer-reviewed, open access title focused on clinical practice and research on all types of human brain and central nervous system disorders.该刊自述为一份国际性，同行评审，开放获取的刊物，聚焦各类人类大脑与中枢神经系统疾病的临床实践和研究。

• Related genetic topics fall inside its scope.相关的遗传学议题属于其范围之内。

• Related pathophysiological topics are taken as well.相关的病理生理学议题同样被接收。

• Related epidemiological topics complete the four areas named on its home page.相关的流行病学议题补足了其首页列出的四个方向。

• Manuscripts on the epidemiology of brain and central nervous system disorders are accepted.关于大脑与中枢神经系统疾病流行病学的稿件会被接收。

• Manuscripts on pathophysiology are accepted.关于病理生理学的稿件会被接收。

• Manuscripts on diagnosis are accepted.关于诊断的稿件会被接收。

• Manuscripts on prognosis are accepted.关于预后的稿件会被接收。

• Manuscripts on treatment are accepted.关于治疗的稿件会被接收。

• The journal presents itself as a multidisciplinary platform for neuroscientists, physicians, psychologists, neurobiologists and other researchers in related fields.该刊把自己呈现为多学科平台，服务对象包括神经科学家，医师，心理学家，神经生物学家以及相关领域的其他研究者。

• Alzheimer's disease is the first of the conditions it names.阿尔茨海默病是它所点名的第一种疾病。

• Parkinson's disease is named too.帕金森病也在其列。

• Multiple sclerosis and brain tumours are both covered.多发性硬化与脑肿瘤都在覆盖范围之内。

• Epilepsy and stroke appear on the same list.癫痫与中风出现在同一份清单上。

• Other neurodegenerative diseases affecting the brain and the spinal cord are included, so the list is not closed.其他累及大脑与脊髓的神经退行性疾病同样被纳入，因此这份清单并不封闭。

• All articles are listed on PubMed, and they are freely available through PubMed Central as well.全部文章都在 PubMed 有记录，并且可以通过 PubMed Central 免费获取。

• Authors choose between a CC BY licence and a CC BY-NC licence.作者可在 CC BY 许可与 CC BY-NC 许可之间选择。

• An article processing charge of 2650 United States dollars applies, and the publisher offers waivers.文章处理费为 2650 美元，出版方另设减免渠道。

• The open access directory gives eight weeks as the median time from submission to publication.开放获取目录把从投稿到发表的中位时间记为八周。

• Special collections are open for submission, and each has its own guest editors.该刊设有开放的专题集，每个专题集都有自己的客座编辑。

• Submissions are screened for plagiarism before they go to a reviewer.投稿在送交评审人之前会经过重复度检测。

• No charge other than the article processing charge is levied on authors.除文章处理费之外，该刊不向作者收取其他费用。

• The directory files the title under three keywords, human brain, neurosurgery and neuropathology.该目录以人类大脑，神经外科与神经病理三个关键词归档该刊。

History

• The predecessor title, Journal of Brain Disease, began in 2009 under Libertas Academica in Auckland.其前身《脑疾病杂志》2009 年由奥克兰的 Libertas Academica 出版。

• That earlier journal carried the number 1179-0636.更早的那份刊物使用刊号 1179-0636。

• The present title began with the 2010 issue and continued the numbering of its predecessor.现名自 2010 年那一期开始使用，并延续前身的卷号。

• Articles are added irregularly through the year and then collected into annual issues.文章在年内不定期加入，随后汇入年度各期。

• One volume covers a year, so volume 2 belongs to 2010 and volume 18 to 2026.每年一卷，因此第 2 卷对应 2010 年，第 18 卷对应 2026 年。

• From 2016 the journal has been published in Thousand Oaks, California, by SAGE Publications.自 2016 年起，该刊由 SAGE 在加利福尼亚州千橡市出版。

• Its DOIs began under the 10.4137 prefix and later moved to the 10.1177 prefix.其 DOI 起初使用 10.4137 前缀，后来改为 10.1177 前缀。

• The electronic number is 1179-5735, and there is no print number.其电子刊号为 1179-5735，没有印本刊号。

• PubMed coverage begins with volume 2 in 2010, and the title is also in PubMed Central.PubMed 的收录从 2010 年的第 2 卷开始，该刊同时进入 PubMed Central。

• The National Library of Medicine indexes the title under brain diseases and central nervous system diseases.美国国立医学图书馆以脑疾病与中枢神经系统疾病两个主题词标注该刊。

• The 2025 impact factor is 2.4 and the five-year figure is 3.9, which places the journal in the third quartile of clinical neurology at 168 of 296.该刊 2025 年影响因子为 2.4，五年影响因子为 3.9，在临床神经病学类目中位列第三象限，296 份中第 168 位。

• Its snapshot records 775 citations and 23 articles, with a cited half-life of 5.2 years.其快照记录总被引 775 次，年发文 23 篇，被引半衰期 5.2 年。

• The gold open access share is complete, and Crossref carries just over three hundred items for the title.金色开放获取占比为全部，Crossref 名下记录到略多于三百条条目。

• The journal has kept one volume a year since 2010, and its volume sequence has never restarted.该刊自 2010 年起保持每年一卷，卷号从未重新起算。

• Its Library of Congress class is neurology and diseases of the nervous system.其美国国会图书馆分类为神经病学与神经系统疾病。

• The open access directory has listed the title since February 2011.开放获取目录自 2011 年 2 月起收录该刊。

• The library created its catalogue record in December 2009, before the first issue under the present name.该馆于 2009 年 12 月建立编目记录，时在现名首期之前。

• The title is indexed in the Emerging Sources Citation Index.该刊被新兴来源引文索引收录。

• The directory records that authors do not retain copyright in their articles.该目录记录作者不保留其文章的版权。

• OpenAlex counts 306 works and an h-index of 34 for the title.OpenAlex 为该刊计得 306 篇作品，h 指数为 34。

• Its papers are grouped first under multiple sclerosis research and then under acute ischemic stroke management.其论文首先被归入多发性硬化研究，其次归入急性缺血性卒中处理。

• Every article carries a DOI as its persistent identifier.每篇文章都以 DOI 作为持久标识符。

Editors

• (Chunlong Zhong) of Shanghai East Hospital at Tongji University is a member of the editorial board and chairs the department of neurosurgery there.（Chunlong Zhong）任职于同济大学附属上海市东方医院，是编委会成员，并担任该院神经外科主任。

• His clinical work centres on minimally invasive surgery for brain tumours, cerebrovascular disease and lesions of the spinal cord.他的临床工作集中于脑肿瘤，脑血管病与脊髓病变的微创手术。

• His research addresses traumatic brain injury and new strategies for treating neuro-oncological disease.其研究涉及颅脑创伤以及神经肿瘤治疗的新策略。

• He has held five grants from the National Natural Science Foundation of China as principal investigator.他曾以负责人身份主持五项国家自然科学基金项目。

• His honours include the Wang Zhongcheng annual award for Chinese neurosurgeons and a first prize in the Shanghai science and technology awards.他所获荣誉包括王忠诚中国神经外科医师年度奖与上海市科技进步一等奖。

• The board is drawn from neuroscientists, physicians, psychologists and neurobiologists, which matches the readership the journal describes.编委会由神经科学家，医师，心理学家与神经生物学家组成，与该刊自述的读者群相合。

• Manuscripts are reviewed in a single anonymous process, with the reviewer's identity withheld from the author.稿件采用单匿名评审，评审人的身份不向作者公开。

• Submissions are handled in ScholarOne Manuscript Central.投稿在 ScholarOne Manuscript Central 系统中处理。

• The journal is a member of the Committee on Publication Ethics.该刊是出版伦理委员会的成员。

• Special collections have their own guest editors, and one recent collection on low-dose radiation therapy in Alzheimer's disease was edited by (Anna Maria Lavezzi) of the University of Milan.专题集由各自的客座编辑主持，近期一个关于低剂量放射治疗阿尔茨海默病的专题集即由米兰大学的（Anna Maria Lavezzi）主编。

• Waivers of the article processing charge are granted under the publisher's own policy.文章处理费的减免按出版方自订的政策审批。

• The board page is maintained by the publisher and lists every member with an institution.编委页面由出版方维护，逐位列出成员及其机构。